Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
MarketWatch· Jaimy Lee· Sep 21, 2026 · 8:58 AM
Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories

marketsabout 4 hours ago
AI giants sued in California over alleged illegal pact to slow AI development
Yahoo Finance

marketsabout 4 hours ago
Why Is Bitcoin Up Today? It Closed Above Its 50-Week Average for the First Time in 45 Weeks.
Yahoo Finance

marketsabout 4 hours ago
Marvell Technology Fell Hard Over 3 Months: It Has Momentum and a Wall Street Pro’s Confidence That 78% Gains are Coming
Yahoo Finance